Inside RNAi with Arrowhead Pharmaceuticals' Javier San Martin

<p>Arrowhead Pharmaceuticals is a biopharmaceutical company based in Pasadena, CA that develops medicines that treat intractable diseases by silencing the genes that cause them. Javier San Martin, Arrowhead&apos;s CMO, talks to Cell &amp; Gene: The Podcast listeners about the similarities and differences between RNAi and CRISPR. He also explains the roadmap for RNAi as well as the company&apos;s pipeline development strategy, which includes pre-clinical to Phase 3 trials.</p>